Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India

A quadrivalent split-virion inactivated influenza vaccine (IIV4; Fluzone® Quadrivalent, Sanofi Pasteur) has been available in the US since 2013 for individuals aged ≥ 6 months. Here, we describe the results of an open-label, multicenter trial (WHO Universal Trial Number U1111-1143–8370) evaluating t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Agarkhedkar, Sharad, Chhatwal, Jugesh, Kompithra, Rajeev Zachariah, Lalwani, Sanjay K., Narayan, Arun, Muninarayanaswam, Vinay, Gogtay, Nithya, Dotter, Kristin, Gresset-Bourgeois, Viviane
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Short Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6605869/
https://ncbi.nlm.nih.gov/pubmed/30762467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1565259
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars